Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + alfentanil vs remimazolam + remifentanil in hysteroscopy
ChiCTR2100044177Phase 4Recruiting
- Sponsor
- Mengcheng County No. 1 People's Hospital
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, alfentanil and remifentanil in menstrual disorders (2 arms), sponsored by Mengcheng County No. 1 People's Hospital. Primary endpoints: MOAA/S score, Sedative dosage and 2 more. Started May 2021; status: recruiting.
02
Drugs
remimazolamalfentanilremifentanil
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ChiCTR2100044177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044177.